Home › Funds › BONNESS ENTERPRISES INC › ABT

BONNESS ENTERPRISES INC position in ABT

ABBOTT LABORATORIES · Health Care

BONNESS ENTERPRISES INC reported holding 32,700 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 1.05% of its reported portfolio and ranking #21 among its reported holdings. BONNESS ENTERPRISES INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)32.70K sh
Reported value held$3.23M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How BONNESS ENTERPRISES INC's ABT position evolved

BONNESS ENTERPRISES INC first disclosed a stake in ABT in Q3 2023 at 32,700 shares (US$3.2M). The position peaked in Q2 2025 at 32,700 shares, worth US$4.4M. Across 13 filings, BONNESS ENTERPRISES INC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 32,700 shares valued at US$3.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.70K $3.17M New
Q4 2023 32.70K $3.60M Hold
Q1 2024 32.70K $3.72M Hold
Q2 2024 32.70K $3.40M Hold
Q3 2024 32.70K $3.73M Hold
Q4 2024 32.70K $3.70M Hold
Q1 2025 32.70K $4.34M Hold
Q2 2025 32.70K $4.45M Hold
Q3 2025 32.70K $4.38M Hold
Q4 2025 32.70K $4.10M Hold
Q1 2026 32.70K $3.36M Hold
Q2 2026 32.70K $2.97M Hold
Q3 2026 32.70K $3.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BONNESS ENTERPRISES INC held ABT?

BONNESS ENTERPRISES INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BONNESS ENTERPRISES INC's current position in ABT?

As of Q3 2026, BONNESS ENTERPRISES INC holds 32.70K shares of ABT (ABBOTT LABORATORIES), valued at $3.23M, representing 1.05% of its reported portfolio and ranking #21.

Has BONNESS ENTERPRISES INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), BONNESS ENTERPRISES INC held unchanged its position in ABT. The position peaked in Q2 2025 at 32.70K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.